Back

Long-term recurrence-free survival following second-generation cryoballoon ablation for persistent atrial fibrillation: role of the autonomic nervous system

8 April 2024 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 4 - ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Denise Guckel

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

8 More presentations in this session

Presentation thumbnail
Extended period rhythm outcomes of posterior box isolation of left atrium during pan-spectrum of atrial fibrillation catheter ablation in 4 randomized clinical trials
Doctor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Validation of the Castle HTx data in a real world scenario
Doctor C. Scheurlen (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Predictive value of guideline-referred risk scores in estimating left atrial low voltage areas and recurrence of atrial fibrillation in repeat ablation procedures
Doctor C. Georgi (Bernau, DE)
Abstract Slides Video
Presentation thumbnail
Radiofrequency balloon ablation: 1-year outcomes of the AURORA registry
Doctor I. My (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Effectiveness of a novel integrated dilator-needle transseptal crossing device in atrial fibrillation cryoballoon ablation procedures.
Doctor J. Benezet Mazuecos (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 4 - ablation

The Event

Event poster

EHRA 2024

8 April 2024 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Very long-term follow-up of pulmonary vein isolation using cryoballoon for catheter ablation for atrial fibrillation
thumbnail
Congress Session
Atrial fibrillation catheter ablation (1)
thumbnail
Congress Presentation
First-pass isolation as an independent predictor of atrial fibrillation recurrence after cryoballoon ablation in patients with persistent atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources